Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2007
08/22/2007EP1572892A4 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
08/22/2007EP1572670B1 5-substituted-pyrazine or -pyridine glucokinase activators
08/22/2007EP1534807B1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid
08/22/2007EP1499320B1 Novel compounds
08/22/2007EP1490405B1 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
08/22/2007EP1467728B1 Pharmaceutical compositions comprising valsartan and nep inhibitors
08/22/2007EP1448523B1 Heterocyclic compounds and methods of use
08/22/2007EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
08/22/2007EP1227813B1 REVERSE-TURN MIMETICS AS alpha 4ß INTEGRIN INHIBITORS
08/22/2007EP1178952B1 Novel interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators
08/22/2007EP1157040B1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
08/22/2007EP0877555B1 Use of an inhibitor of an immune system costimulation event for the preparation of a medicament inhibiting the immune system destruction of transplanted viable non-embryonic cells
08/22/2007CN1332974C Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use
08/22/2007CN1332971C Luteolin-7-O-bata-glucuronide and its extracting process and application thereof
08/22/2007CN1332968C Mangiferin derivatives and its prepn. method, and use as medicine
08/22/2007CN1332961C Inhibitors of alpha L beta 2 mediated cell adhesion
08/22/2007CN1332960C Imidazoquinoline derivatives as adenosine A3 receptor ligands
08/22/2007CN1332954C Dipeptidyl peptidase IV effectors
08/22/2007CN1332711C Method for administering GLP-1 molecules
08/22/2007CN1332691C Medication for treating cardiovascular diseases prepared from byproduct of solution from 'Huangjiang' in producing saponin
08/22/2007CN1332687C Fatty acid synthetic enzyme inhibitor and its production method and application
08/22/2007CN1332676C Preparation for enriching calcium and preparation method
08/22/2007CN1332674C Method for preparing Chinese medicinal formulation of dog button
08/22/2007CN1332657C Composition containing lovastatin and use thereof
08/22/2007CN101023083A Nitrogenous fused bicyclic compound
08/22/2007CN101022821A Use of aspartate for regulating glucose levels in blood
08/22/2007CN101022817A Therapeutic or preventive agent for diabetic neuropathy
08/22/2007CN101022814A Composition containing swelling agent comprising swellable water-soluble polysaccharide and food, obesity preventive, and constipation alleviator each containing the composition
08/22/2007CN101022809A Dihydropteridinones for the treatment of cancer diseases
08/22/2007CN101022801A Use of N-aryl diazaspiracyclic compounds in the treatment of addiction
08/22/2007CN101020684A Formononetin-3'-sodium sulfonate, prunetin-3'-sodium sulfonate and their prepn process and medicinal use
08/22/2007CN101020655A Process of extracting 1-deoxy nojirimycin
08/22/2007CN101020651A Creatine calcium and its prepn and application
08/22/2007CN101020063A Vaccine for preventing and/or treating autoimmune disease
08/22/2007CN101020047A Health food containing calcium reinforcing agent
08/22/2007CN101020041A Antilipemic health product
08/22/2007CN101020025A Antilipemic health product
08/22/2007CN101020021A Antilipemic health product
08/22/2007CN101020013A Hypoglycemic and antilipemic health product and its prepn
08/22/2007CN101019997A Antilipemic health product
08/22/2007CN101019988A Diabetes treating Chinese medicine
08/22/2007CN101019969A Antilipemic health product
08/22/2007CN101019961A Antilipemic health product
08/22/2007CN101019946A Obesity treating Chinese medicine and its prepn process
08/22/2007CN101019927A Chinese medicine prepn for treating diabetes
08/22/2007CN101019909A Supercritical safflower extracting process
08/22/2007CN101019900A Health product with auxiliary antilipemic function and its prepn
08/22/2007CN101019895A Health product for reducing blood sugar and its prepn
08/22/2007CN101019888A Medicine for treating fatty liver and alcoholic hepatitis and reducing blood fat and transaminase
08/22/2007CN101019874A Acarbose medicine composition and its prepn
08/22/2007CN101019852A Freeze dried prepn of medium chain fatty acid liposome and its prepn process
08/22/2007CN101019851A Medium chain fatty acid liposome and its prepn
08/22/2007CN101019848A Application of ferricitras in preparation of medicine to prevent and treat angiosteosis
08/22/2007CN101019846A Prepn of capsule containing pyruvic acid and its salt
08/22/2007CN101019839A Application of beta-elemene in preparing hypoglycemic medicine
08/22/2007CN101019824A Oral medicine composition containing salvianolic acid and its prepn
08/22/2007CN101019823A Separately packed structural fatty milk, aminoacid and glucose injection composition and the prepn process
08/22/2007CN101019822A Separately packed fatty milk, amino acid and glucose injection composition and the prepn process
08/22/2007CN101019677A Sugar-less buckwheat flavone beverage
08/22/2007CN101019667A Algae-bean food
08/22/2007CN101019655A Prepn of milk coated heme polypeptide
08/22/2007CN101019654A Health rice with stable blood sugar content after meal and its production process
08/22/2007CN101019649A Health product for improving sleep
08/22/2007CN101019648A Health product for reducing blood pressure
08/22/2007CN101019647A Health product for reducing blood pressure
08/22/2007CN101019646A Health product for promoting lactation
08/22/2007CN101019645A Health food for remitting fatigue and raising hypoxia tolerance and its prepn
08/22/2007CN101019643A Bown sugar health product capable of raising women's immunity
08/22/2007CN101019642A Brown sugar health product capable of raising immunity of puerpera
08/22/2007CN101019641A Process of producing black food containing plant melanin
08/22/2007CN101019627A Micro jet and instantaneous high pressure process of preparing whole lily powder
08/22/2007CN101019592A 竹盐口香糖及泡泡糖 Bamboo salt chewing gum and bubble gum
08/22/2007CN101019589A Tea granule preparing process
08/22/2007CN101019588A Bagged lung heat eliminating tea
08/22/2007CN101019585A Production process of serial health Puer tea with gastrodia tuber
08/21/2007US7259233 Chronic treatment regimen using glucagon-like insulinotropic peptides
08/21/2007US7259187 Tropolone derivatives
08/21/2007US7259179 Kinase inhibitors
08/21/2007US7259177 Containing an oxazole ring 2-phenyl-, furanyl- or thiophenyl-substituted; e.g., 2,2-Dimethyl-4-[3-(5-methyl-2-p-tolyloxazol-4-ylmethoxy)cyclohexyl]-butyric acid; treating disorders of fatty acid metabolism, glucose utilization disorders, and also of disorders in which insulin resistance is involvolved
08/21/2007US7259175 Alkanoic acids substituted with a group containing pyridinyl-, pyrimidinyl- or pyrazinyl-phenyl linked through a thiazolyl- or oxazolyl- phenyl group; e.g., 3-[4-(2-{2-[6-(2-Fluoro-phenyl)-pyridin-3-yl]-5-methyl-thiazol-4-yl}-ethoxy)-2-methyl-phenyl]-propionic acid; treating diabetes and atherosclerosis
08/21/2007US7259170 Macrolides containing pharmaceutical compositions
08/21/2007US7259166 Substituted-cycloalkyl and oxygenated-cycloalkyl glucokinase activators
08/21/2007US7259160 Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
08/21/2007US7259148 Hepatoprotective activity of 2′-p-hydroxybenzoylmussaenosidic acid
08/21/2007US7258861 Peptides derived from the region of human TNF- alpha from Ser100 to Glu116 to treat pulmonary oedema.
08/21/2007CA2332790C Controlled release lipoic acid
08/21/2007CA2320368C Composition comprising theanine
08/21/2007CA2315827C Substituted pyridine and pyridazine compounds and their pharmaceutical use
08/21/2007CA2294036C Polyallylamine polymers for treating hypercholesterolemia
08/16/2007WO2007092755A2 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
08/16/2007WO2007092751A2 Compounds and methods for modulating fx-receptors
08/16/2007WO2007092638A1 Bicyclic sphingosine 1-phosphate analogs
08/16/2007WO2007092469A2 Combination of organic compounds
08/16/2007WO2007092400A1 Aminophenyl derivatives as selective androgen receptor modulators
08/16/2007WO2007092086A2 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
08/16/2007WO2007092023A1 Compositions and methods for binding or inactivating ghrelin
08/16/2007WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same
08/16/2007WO2007091140A1 Substituted phenylsulfamoyl compounds as ppar agonists
08/16/2007WO2007090752A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
08/16/2007WO2007090289A1 Combinations of botanical extracts for promoting cardiovascular health